Delivery Order SPE2DB22D3501-SPE2DB23FXG56
Award Date 9/19/23
Potential Completion Date 9/20/23
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM42E, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,485.50 delivery order contract is for the supply of 4,563,458,779 units of Rosuvastatin Calcium 40 mg tablets, with a completion date of January 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $59,871.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,618,267 units of rosuvastatin calcium 40 mg tablets over a period ending on August 29, 2024. This is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- The federal contract award is for the delivery of Rosuvastatin Calcium 40 mg tablets in quantities of 500 per bottle. The contract, valued at $81,253.24, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of December 18, 2024. While the original solicitation is not provided, the contract appears to be part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $157,458.83 firm fixed-price delivery order is for the supply of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $173,843.44 Firm Fixed Price Delivery Order covers the supply of 4,563,604,394 units of Rosuvastatin Calcium 40 mg Tablets in 500-count packages. The award is not designated as a set-aside and was made through full and open competition. It is associated with a larger Indefinite Delivery Contract (IDC) between the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,164.29, is for the delivery of Rosuvastatin Calcium 40 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award, identified as SPE2DB20D2014|SPE2DB24FA26F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,228.46 firm fixed-price delivery order is for the supply of 500 units of Rosuvastatin Calcium 40 mg tablets. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The federal contract award SPE2DB22D2206|SPE2DB23FHJ61 was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4,561,055,395 units of Rosuvastatin Calcium 40 mg tablets. The $86,664.85 firm fixed-price delivery order contract has a completion date of May 26, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $26,023.34 firm fixed-price delivery order contract is for the supply of 4,564,414,347 units of Rosuvastatin Calcium 20 mg tablets. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,811.90 Firm Fixed Price Delivery Order is for the provision of 4,565,048,564 units of Rosuvastatin Calcium 10 mg tablets. The contract has an ultimate completion date of July 2, 2024 and was awarded on July 1, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...